Symbols / BIO Stock $279.34 -2.77% Bio-Rad Laboratories, Inc.

Healthcare • Medical Devices • United States • NYQ
BIO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Norman D. Schwartz
Exch · Country NYQ · United States
Market Cap 7.54B
Enterprise Value 7.38B
Income 759.90M
Sales 2.58B
FCF (ttm) 256.55M
Book/sh 276.16
Cash/sh 57.08
Employees 7,450
Insider 10d —
IPO Feb 27, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 10.03
Forward P/E 24.62
PEG 4.01
P/S 2.92
P/B 1.01
P/C —
EV/EBITDA 17.11
EV/Sales 2.86
Quick Ratio 3.89
Current Ratio 5.62
Debt/Eq 18.58
LT Debt/Eq —
EPS (ttm) 27.85
EPS next Y 11.35
EPS Growth —
Revenue Growth 3.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-12
ROA 1.67%
ROE 10.84%
ROIC —
Gross Margin 52.01%
Oper. Margin 8.87%
Profit Margin 29.42%
Shs Outstand 21.92M
Shs Float 21.13M
Insider Own 16.21%
Instit Own 91.26%
Short Float 0.00%
Short Ratio 0.00
Short Interest 29.00
52W High 343.12
vs 52W High -18.59%
52W Low 211.43
vs 52W Low 32.12%
Beta 1.16
Impl. Vol. 0.20%
Rel Volume 0.97
Avg Volume 295.84K
Volume 286.95K
Target (mean) $302.50
Tgt Median $305.00
Tgt Low $280.00
Tgt High $320.00
# Analysts 4
Recom None
Prev Close $287.29
Price $279.34
Change -2.77%
About

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$302.50
Mean price target
2. Current target
$279.34
Latest analyst target
3. DCF / Fair value
$210.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$279.34
Low
$280.00
High
$320.00
Mean
$302.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-07 down Citigroup Buy → Neutral $300
2025-10-30 main Citigroup Buy → Buy $375
2025-10-30 main Wells Fargo Equal-Weight → Equal-Weight $340
2025-08-01 main RBC Capital Outperform → Outperform $409
2025-08-01 main Wells Fargo Equal-Weight → Equal-Weight $265
2025-06-09 main Wells Fargo Equal-Weight → Equal-Weight $245
2025-05-02 main UBS Buy → Buy $310
2025-05-02 main Citigroup Buy → Buy $350
2025-05-02 main RBC Capital Outperform → Outperform $392
2025-04-17 main Wells Fargo Equal-Weight → Equal-Weight $270
2025-02-12 main Wells Fargo Equal-Weight → Equal-Weight $345
2025-01-14 reit RBC Capital Outperform → Outperform $481
2024-12-09 main RBC Capital Outperform → Outperform $481
2024-10-31 main Citigroup Buy → Buy $450
2024-10-31 main RBC Capital Outperform → Outperform $469
2024-10-01 up Citigroup Neutral → Buy $400
2024-08-27 init Wells Fargo — → Equal-Weight $340
2024-08-16 reit RBC Capital Outperform → Outperform $401
2024-08-02 main RBC Capital Outperform → Outperform $401
2024-08-02 main Citigroup Neutral → Neutral $350
News
RSS: Latest BIO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-21 PEI MELINDA LITHERLAND Director — 407 — —
2026-04-21 PINKSTON ARNOLD A Director — 407 — —
2026-04-21 HINCKLEY GREGORY K Director — 407 — —
2026-04-21 EDWARDS JEFFREY L Director — 407 — —
2025-11-06 BARRY JAMES Officer — 699 $306.18 $214,289
2025-10-24 DIVINCENZO JONATHAN P President — 1,869 — —
2025-10-20 EVRAN SEDAT Officer — 1,044 — —
2025-09-05 ALLISON SCHWARTZ Director — 92 — —
2025-09-05 COREY COLLEEN Officer — 576 — —
2025-09-05 EVRAN SEDAT Officer — 864 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,583.20
+0.65%
2,566.50
-3.92%
2,671.20
-4.67%
2,802.20
Operating Revenue
2,583.20
+0.65%
2,566.50
-3.92%
2,671.20
-4.67%
2,802.20
Cost Of Revenue
1,243.30
+4.69%
1,187.60
-4.56%
1,244.30
+0.76%
1,234.90
Reconciled Cost Of Revenue
1,243.30
+4.69%
1,187.60
-4.56%
1,244.30
+0.76%
1,234.90
Gross Profit
1,339.90
-2.83%
1,378.90
-3.36%
1,426.90
-8.96%
1,567.30
Operating Expense
1,121.30
+1.03%
1,109.90
+1.91%
1,089.10
-0.28%
1,092.20
Research And Development
275.60
-6.86%
295.90
+19.60%
247.40
-3.70%
256.90
Selling General And Administration
844.30
+3.72%
814.00
-3.29%
841.70
+1.68%
827.80
Other Operating Expenses
—
—
—
7.50
Total Expenses
2,364.60
+2.92%
2,297.50
-1.54%
2,333.40
+0.27%
2,327.10
Operating Income
218.60
-18.74%
269.00
-20.37%
337.80
-28.90%
475.10
Total Operating Income As Reported
47.20
-82.45%
269.00
-20.37%
337.80
-30.00%
482.60
EBITDA
1,209.90
+156.48%
-2,142.00
-227.12%
-654.80
+85.54%
-4,528.80
Normalized EBITDA
480.70
-4.66%
504.20
-14.11%
587.00
-12.75%
672.80
Reconciled Depreciation
165.40
+9.10%
151.60
+3.91%
145.90
+6.26%
137.30
EBIT
1,044.50
+145.54%
-2,293.60
-186.45%
-800.70
+82.84%
-4,666.10
Total Unusual Items
729.20
+127.56%
-2,646.20
-113.09%
-1,241.80
+76.13%
-5,201.60
Total Unusual Items Excluding Goodwill
729.20
+127.56%
-2,646.20
-113.09%
-1,241.80
+76.13%
-5,201.60
Special Income Charges
-178.80
0.00
-100.00%
2.50
+123.81%
-10.50
Other Special Charges
—
—
-2.50
—
Impairment Of Capital Assets
172.80
0.00
0.00
—
Write Off
6.00
0.00
0.00
-100.00%
11.90
Net Income
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Pretax Income
995.50
+142.50%
-2,342.50
-175.56%
-850.10
+81.93%
-4,704.20
Net Non Operating Interest Income Expense
46.50
+40.48%
33.10
-35.73%
51.50
+157.50%
20.00
Interest Expense Non Operating
49.00
+0.20%
48.90
-1.01%
49.40
+29.66%
38.10
Net Interest Income
46.50
+40.48%
33.10
-35.73%
51.50
+157.50%
20.00
Interest Expense
49.00
+0.20%
48.90
-1.01%
49.40
+29.66%
38.10
Interest Income Non Operating
95.50
+16.46%
82.00
-18.73%
100.90
+73.67%
58.10
Interest Income
95.50
+16.46%
82.00
-18.73%
100.90
+73.67%
58.10
Other Income Expense
730.40
+127.62%
-2,644.60
-113.38%
-1,239.40
+76.16%
-5,199.30
Other Non Operating Income Expenses
1.20
-25.00%
1.60
-33.33%
2.40
+4.35%
2.30
Gain On Sale Of Security
908.00
+134.31%
-2,646.20
-112.67%
-1,244.30
+76.03%
-5,191.10
Gain On Sale Of Business
—
0.00
-100.00%
2.50
+78.57%
1.40
Tax Provision
235.60
+147.28%
-498.30
-134.16%
-212.80
+80.24%
-1,076.70
Tax Rate For Calcs
0.00
+11.26%
0.00
-14.91%
0.00
+9.17%
0.00
Tax Effect Of Unusual Items
172.58
+130.66%
-562.90
-81.32%
-310.45
+73.94%
-1,191.17
Net Income Including Noncontrolling Interests
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Net Income From Continuing Operation Net Minority Interest
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Net Income From Continuing And Discontinued Operation
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Net Income Continuous Operations
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Normalized Income
203.28
-14.98%
239.10
-18.69%
294.05
-23.21%
382.93
Net Income Common Stockholders
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Diluted EPS
27.85
+142.61%
-65.36
-199.54%
-21.82
+82.08%
-121.79
Basic EPS
27.87
+142.64%
-65.36
-199.54%
-21.82
+82.08%
-121.79
Basic Average Shares
27.26
-3.37%
28.21
-3.41%
29.21
-1.93%
29.79
Diluted Average Shares
27.28
-3.31%
28.21
-3.41%
29.21
-1.93%
29.79
Diluted NI Availto Com Stockholders
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Provision For Doubtful Accounts
1.40
0.00
0.00
-100.00%
7.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
10,576.50
+12.95%
9,364.10
-23.86%
12,299.10
-8.91%
13,501.67
Current Assets
2,906.20
-4.10%
3,030.30
-0.59%
3,048.30
-3.47%
3,157.98
Cash Cash Equivalents And Short Term Investments
1,540.70
-7.44%
1,664.50
+3.57%
1,607.10
-10.25%
1,790.67
Cash And Cash Equivalents
529.80
+8.54%
488.10
+20.88%
403.80
-7.00%
434.21
Other Short Term Investments
1,010.90
-14.07%
1,176.40
-2.24%
1,203.30
-11.29%
1,356.46
Receivables
460.60
+1.79%
452.50
-7.46%
489.00
-1.14%
494.64
Accounts Receivable
460.60
+1.79%
452.50
-7.46%
489.00
-1.14%
494.64
Gross Accounts Receivable
466.10
+0.95%
461.70
-8.37%
503.90
-1.13%
509.67
Allowance For Doubtful Accounts Receivable
-5.50
+40.22%
-9.20
+38.26%
-14.90
+0.86%
-15.03
Inventory
740.70
-2.54%
760.00
-2.63%
780.50
+8.51%
719.32
Raw Materials
212.50
-4.28%
222.00
-4.15%
231.60
+1.22%
228.80
Work In Process
234.90
-3.41%
243.20
-1.14%
246.00
+11.36%
220.90
Finished Goods
293.30
-0.51%
294.80
-2.67%
302.90
+12.35%
269.60
Prepaid Assets
136.50
+11.34%
122.60
-12.43%
140.00
+12.74%
124.18
Restricted Cash
—
0.00
-100.00%
5.60
+0.72%
5.56
Other Current Assets
27.70
-9.77%
30.70
+17.62%
26.10
+10.57%
23.60
Total Non Current Assets
7,670.30
+21.10%
6,333.80
-31.53%
9,250.80
-10.57%
10,343.64
Net PPE
709.90
+3.09%
688.60
-4.85%
723.70
+6.50%
679.55
Gross PPE
1,970.90
+9.63%
1,797.80
+0.41%
1,790.40
+6.01%
1,688.95
Accumulated Depreciation
-1,261.00
-13.69%
-1,109.20
-3.98%
-1,066.70
-5.68%
-1,009.40
Properties
0.00
0.00
0.00
0.00
Land And Improvements
28.90
+3.96%
27.80
-2.11%
28.40
+2.16%
27.80
Buildings And Improvements
449.40
+5.42%
426.30
+1.55%
419.80
+6.66%
393.60
Other Properties
1,492.60
+11.08%
1,343.70
+0.11%
1,342.20
+5.89%
1,267.55
Goodwill And Other Intangible Assets
754.10
+7.10%
704.10
-4.09%
734.10
-0.61%
738.60
Goodwill
579.80
+41.24%
410.50
-0.75%
413.60
+1.75%
406.50
Other Intangible Assets
174.30
-40.63%
293.60
-8.39%
320.50
-3.49%
332.10
Investments And Advances
6,103.60
+26.13%
4,839.20
-37.14%
7,698.10
-12.83%
8,830.89
Other Investments
6,103.60
+26.13%
4,839.20
-37.14%
7,698.10
-12.83%
8,830.89
Other Non Current Assets
102.70
+0.79%
101.90
+7.38%
94.90
+0.32%
94.60
Total Liabilities Net Minority Interest
3,122.90
+11.74%
2,794.80
-21.45%
3,557.90
-8.45%
3,886.41
Current Liabilities
517.00
+10.52%
467.80
-10.52%
522.80
-8.07%
568.71
Payables And Accrued Expenses
337.90
+21.68%
277.70
-13.30%
320.30
-11.58%
362.26
Payables
165.60
+7.88%
153.50
-14.91%
180.40
+7.72%
167.47
Accounts Payable
129.00
+5.48%
122.30
-15.42%
144.60
+7.08%
135.04
Current Accrued Expenses
172.30
+38.73%
124.20
-11.22%
139.90
-28.18%
194.79
Total Tax Payable
36.60
+17.31%
31.20
-12.85%
35.80
+10.40%
32.43
Income Tax Payable
—
—
—
11.93
Current Debt And Capital Lease Obligation
37.40
-12.82%
42.90
+4.89%
40.90
+11.14%
36.80
Current Debt
1.30
+8.33%
1.20
+140.00%
0.50
+7.53%
0.47
Other Current Borrowings
1.30
+8.33%
1.20
+140.00%
0.50
+7.53%
0.47
Current Capital Lease Obligation
36.10
-13.43%
41.70
+3.22%
40.40
+11.18%
36.34
Current Deferred Liabilities
—
—
—
52.21
Current Deferred Revenue
—
—
—
52.21
Other Current Liabilities
141.70
-3.74%
147.20
-8.91%
161.60
-4.74%
169.65
Total Non Current Liabilities Net Minority Interest
2,605.90
+11.99%
2,327.00
-23.33%
3,035.10
-8.52%
3,317.71
Long Term Debt And Capital Lease Obligation
1,348.70
+1.27%
1,331.80
-2.40%
1,364.60
+0.98%
1,351.30
Long Term Debt
1,203.00
+0.22%
1,200.40
+0.11%
1,199.10
+0.12%
1,197.70
Long Term Capital Lease Obligation
145.70
+10.88%
131.40
-20.60%
165.50
+7.75%
153.60
Non Current Deferred Liabilities
1,059.40
+29.51%
818.00
-44.56%
1,475.50
-16.66%
1,770.48
Non Current Deferred Taxes Liabilities
1,059.40
+29.51%
818.00
-44.56%
1,475.50
-16.66%
1,770.48
Other Non Current Liabilities
197.80
+11.63%
177.20
-9.13%
195.00
-0.47%
195.93
Stockholders Equity
7,453.60
+13.46%
6,569.30
-24.85%
8,741.20
-9.09%
9,615.25
Common Stock Equity
7,453.60
+13.46%
6,569.30
-24.85%
8,741.20
-9.09%
9,615.25
Capital Stock
0.00
0.00
0.00
-100.00%
0.00
Common Stock
0.00
0.00
0.00
-100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
30.27
0.00%
30.27
0.00%
30.27
+0.10%
30.24
Ordinary Shares Number
26.99
-3.64%
28.01
-1.78%
28.52
-3.64%
29.60
Treasury Shares Number
3.28
+45.27%
2.25
+29.03%
1.75
+172.83%
0.64
Additional Paid In Capital
476.00
+2.76%
463.20
+3.14%
449.10
+0.37%
447.45
Retained Earnings
8,176.30
+10.25%
7,416.40
-19.91%
9,260.60
-6.44%
9,898.20
Gains Losses Not Affecting Retained Earnings
-189.10
+64.86%
-538.20
-60.18%
-336.00
+28.02%
-466.82
Treasury Stock
1,009.60
+30.76%
772.10
+22.07%
632.50
+139.96%
263.59
Other Equity Adjustments
-189.10
+64.86%
-538.20
-60.18%
-336.00
+28.02%
-466.82
Total Equity Gross Minority Interest
7,453.60
+13.46%
6,569.30
-24.85%
8,741.20
-9.09%
9,615.25
Total Capitalization
8,656.60
+11.41%
7,769.70
-21.84%
9,940.30
-8.07%
10,812.95
Working Capital
2,389.20
-6.76%
2,562.50
+1.47%
2,525.50
-2.46%
2,589.27
Invested Capital
8,657.90
+11.41%
7,770.90
-21.83%
9,940.80
-8.07%
10,813.42
Total Debt
1,386.10
+0.83%
1,374.70
-2.19%
1,405.50
+1.25%
1,388.10
Net Debt
674.50
-5.47%
713.50
-10.34%
795.80
+4.17%
763.95
Capital Lease Obligations
181.80
+5.03%
173.10
-15.93%
205.90
+8.41%
189.93
Net Tangible Assets
6,699.50
+14.22%
5,865.20
-26.75%
8,007.10
-9.80%
8,876.65
Tangible Book Value
6,699.50
+14.22%
5,865.20
-26.75%
8,007.10
-9.80%
8,876.65
Other Inventories
—
—
0.02
+6.25%
0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
532.20
+16.92%
455.20
+21.42%
374.90
+92.85%
194.40
Cash Flow From Continuing Operating Activities
532.20
+16.92%
455.20
+21.42%
374.90
+92.85%
194.40
Net Income From Continuing Operations
759.90
+141.20%
-1,844.20
-189.38%
-637.30
+82.43%
-3,627.50
Depreciation Amortization Depletion
165.40
+9.10%
151.60
+3.91%
145.90
+6.26%
137.30
Depreciation And Amortization
165.40
+9.10%
151.60
+3.91%
145.90
+6.26%
137.30
Other Non Cash Items
-3.30
-106.67%
49.50
+512.50%
-12.00
-154.30%
22.10
Stock Based Compensation
58.00
-6.90%
62.30
+1.63%
61.30
+0.66%
60.90
Provisionand Write Offof Assets
1.40
0.00
0.00
-100.00%
7.50
Asset Impairment Charge
178.80
0.00
0.00
-100.00%
11.90
Operating Gains Losses
—
—
-2.50
-78.57%
-1.40
Unrealized Gain Loss On Investment Securities
-900.40
-133.89%
2,656.80
+112.15%
1,252.30
-75.89%
5,193.60
Change In Working Capital
272.40
+143.88%
-620.80
-43.44%
-432.80
+73.12%
-1,610.00
Change In Receivables
19.60
+20.99%
16.20
+42.11%
11.40
+113.04%
-87.40
Changes In Account Receivables
19.60
+20.99%
16.20
+42.11%
11.40
+113.04%
-87.40
Change In Inventory
68.90
+710.59%
8.50
+118.36%
-46.30
+70.84%
-158.80
Change In Payables And Accrued Expense
1.40
+108.33%
-16.80
+77.02%
-73.10
+23.38%
-95.40
Change In Payable
1.40
+108.33%
-16.80
+77.02%
-73.10
+23.38%
-95.40
Change In Account Payable
-0.10
+99.76%
-40.90
+21.04%
-51.80
+45.01%
-94.20
Change In Other Working Capital
170.50
+127.20%
-626.80
-94.30%
-322.60
+74.02%
-1,241.60
Change In Other Current Assets
12.20
+262.67%
-7.50
-494.74%
1.90
+105.86%
-32.40
Change In Other Current Liabilities
-0.20
-103.57%
5.60
+236.59%
-4.10
-173.21%
5.60
Investing Cash Flow
-189.70
-18.41%
-160.20
-893.07%
20.20
+101.67%
-1,207.60
Cash Flow From Continuing Investing Activities
-189.70
-18.41%
-160.20
-893.07%
20.20
+101.67%
-1,207.60
Net PPE Purchase And Sale
-157.50
+4.83%
-165.50
-5.75%
-156.50
-38.99%
-112.60
Purchase Of PPE
-157.60
+4.83%
-165.60
-5.68%
-156.70
-38.92%
-112.80
Sale Of PPE
0.10
+0.00%
0.10
-50.00%
0.20
+0.00%
0.20
Capital Expenditure
-157.60
+16.61%
-189.00
-20.61%
-156.70
-37.10%
-114.30
Net Investment Purchase And Sale
186.30
+549.13%
28.70
-83.52%
174.20
+117.52%
-994.20
Purchase Of Investment
-669.30
+47.57%
-1,276.60
-85.28%
-689.00
+66.56%
-2,060.20
Sale Of Investment
855.60
-34.45%
1,305.30
+51.22%
863.20
-19.02%
1,066.00
Net Business Purchase And Sale
-218.50
0.00
-100.00%
2.50
+102.52%
-99.30
Purchase Of Business
-218.50
0.00
0.00
+100.00%
-100.70
Gain Loss On Sale Of Business
0.00
0.00
+100.00%
-2.50
-78.57%
-1.40
Net Intangibles Purchase And Sale
0.00
+100.00%
-23.40
0.00
+100.00%
-1.50
Purchase Of Intangibles
0.00
+100.00%
-23.40
0.00
+100.00%
-1.50
Net Other Investing Changes
—
—
—
—
Financing Cash Flow
-283.20
-29.43%
-218.80
+48.59%
-425.60
-143.71%
973.60
Cash Flow From Continuing Financing Activities
-283.20
-29.43%
-218.80
+48.59%
-425.60
-143.71%
973.60
Net Issuance Payments Of Debt
-0.50
-25.00%
-0.40
+20.00%
-0.50
-100.04%
1,185.70
Issuance Of Debt
—
0.00
0.00
-100.00%
1,186.20
Repayment Of Debt
-0.50
-25.00%
-0.40
+20.00%
-0.50
+0.00%
-0.50
Long Term Debt Issuance
—
0.00
0.00
-100.00%
1,186.20
Long Term Debt Payments
-0.50
-25.00%
-0.40
+20.00%
-0.50
+0.00%
-0.50
Net Long Term Debt Issuance
-0.50
-25.00%
-0.40
+20.00%
-0.50
-100.04%
1,185.70
Net Common Stock Issuance
-295.50
-45.14%
-203.60
+52.51%
-428.70
-98.75%
-215.70
Common Stock Payments
-295.50
-45.14%
-203.60
+52.51%
-428.70
-98.75%
-215.70
Repurchase Of Capital Stock
-295.50
-45.14%
-203.60
+52.51%
-428.70
-98.75%
-215.70
Proceeds From Stock Option Exercised
15.80
-17.71%
19.20
+3.78%
18.50
+5.11%
17.60
Net Other Financing Charges
-3.00
+91.18%
-34.00
-128.19%
-14.90
-6.43%
-14.00
Changes In Cash
59.30
-22.18%
76.20
+349.84%
-30.50
+22.98%
-39.60
Effect Of Exchange Rate Changes
-16.90
-283.70%
9.20
+2200.00%
0.40
-86.67%
3.00
Beginning Cash Position
489.80
+21.12%
404.40
-6.93%
434.50
-7.77%
471.10
End Cash Position
532.20
+8.66%
489.80
+21.12%
404.40
-6.93%
434.50
Free Cash Flow
374.60
+40.72%
266.20
+22.00%
218.20
+172.41%
80.10
Change In Income Tax Payable
1.50
-93.78%
24.10
+213.15%
-21.30
-1675.00%
-1.20
Change In Tax Payable
1.50
-93.78%
24.10
+213.15%
-21.30
-1675.00%
-1.20
Sale Of Business
0.00
0.00
-100.00%
2.50
+78.57%
1.40
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category